Physician profile
Steven J Rough
NPI 1386821460
$18,956.07
in general payments reported to CMS, 2019-2025
55 companies · $5,757 in 2025
The $5,757 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,624 · 2020: $1,389 · 2021: $1,846 · 2022: $2,348 · 2023: $1,501 · 2024: $1,491 · 2025: $5,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,946 · Travel and Lodging: $1,738 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,946.06 |
| Travel and Lodging | $1,737.66 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,050.91 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $1,397.89 | 2019-2025 | |
| Medtronic, INC. | $1,354.89 | 2021-2025 | Micra, Linq II, Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $949.15 | 2019-2020 | |
| Biotronik INC. | $849.22 | 2019-2025 | Biomonitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $795.43 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $580.60 | 2019-2024 | Watchman Access System, Watchman Flx, Rotapro |
| Abbott Laboratories | $560.73 | 2019-2025 | Mitraclip, Navitor |
| Abiomed | $469.54 | 2022-2025 | Impella |
| Merck Sharp & Dohme LLC | $445.75 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $433.32 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $422.07 | 2019-2025 | |
| Astellas Pharma US INC | $395.76 | 2019-2023 | Lexiscan |
| Astrazeneca Pharmaceuticals Lp | $394.05 | 2019-2024 | Wainua, Andexxa, Brilinta |
| Actelion Pharmaceuticals US, INC. | $381.95 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.